Tertiary mechanisms of brain damage: A new hope for treatment of cerebral palsy?

The Lancet Neurology

Volumn 11, Issue 6, 2012, Pages 556-566

  Fleiss, Bobbi ^a,b,c,d   Gressens, Pierre ^a,b,c,d  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d PremUP   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM; CD44V ANTIGEN; ERYTHROPOIETIN; EXCITATORY AMINO ACID; FRUCTOSE 1,6 BISPHOSPHATE; GELATINASE B; HISTONE DEACETYLASE; HYALURONIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MELATONIN; MICRORNA; MICRORNA 124; NEUROTRANSMITTER; PHOSPHORUS; SEX HORMONE; SMAD PROTEIN; STEROID; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TRICHOSTATIN A; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULOTROPIN; CELL ADHESION MOLECULE; IMMUNOGLOBULIN CELL ADHESION MOLECULE; PROTEOCHONDROITIN SULFATE; UNCLASSIFIED DRUG;

ACETYLATION; APOPTOSIS; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN DAMAGE; BRAIN DISEASE; BRAIN INJURY; CELL DEATH; CELL MATURATION; CELL PROLIFERATION; CELL REGENERATION; CELL THERAPY; CEREBRAL PALSY; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE ACTIVITY; DISEASE SEVERITY; EMBRYONIC STEM CELL; EPIGENETICS; GENE EXPRESSION; GLIOSIS; GRAFT REJECTION; HOMEOSTASIS; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOMODULATION; INDUCED HYPOTHERMIA; INFLAMMATION; LEARNING DISORDER; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; METABOLIC DISORDER; METHYLATION; MICROGLIA; MOTOR DYSFUNCTION; MYELINATION; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROTOXICITY; NEWBORN DEATH; NEWBORN DISEASE; NONHUMAN; OLIGODENDROGLIA; OUTCOME ASSESSMENT; PARKINSON DISEASE; PHAGOCYTOSIS; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; RNA TRANSLATION; SIGNAL TRANSDUCTION; STEROIDOGENESIS; SUMOYLATION; SYNAPTOGENESIS; TRANSCRIPTION REGULATION; TRAUMATIC BRAIN INJURY; UBIQUITINATION; ENCEPHALITIS; LONG TERM CARE; NEUROPROTECTION; OLIGODENDROCYTE PRECURSOR CELL; PATHOPHYSIOLOGY; PHARMACEUTICAL CARE; WHITE MATTER INJURY;

BRAIN; BRAIN INJURIES; CEREBRAL PALSY; HUMANS; INFANT, NEWBORN;

EID: 84861158230     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(12)70058-3     Document Type: Review

References (129)

1. Bax M, Goldstein M, Rosenbaum P, et al. Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol 2005, 47:571-576.
2. Blair E, Stanley FJ Intrapartum asphyxia: a rare cause of cerebral palsy. J Pediatr 1988, 112:515-519.
3. Graham EM, Ruis KA, Hartman AL, Northington FJ, Fox HE A systematic review of the role of intrapartum hypoxia-ischemia in the causation of neonatal encephalopathy. Am J Obstet Gynecol 2008, 199:587-595.
4. Moreno-De-Luca A, Ledbetter DH, Martin CL Genomic insights into the causes and classification of the cerebral palsies. Lancet Neurol 2012, 11:283-292.
5. Keogh JM, Badawi N The origins of cerebral palsy. Curr Opin Neurol 2006, 19:129-134.
6. Nelson KB Causative factors in cerebral palsy. Clin Obstet Gynecol 2008, 51:749-762.
7. Dammann O Persistent neuro-inflammation in cerebral palsy: a therapeutic window of opportunity?. Acta Paediatr 2007, 96:6-7.
8. Leviton A, Gressens P Neuronal damage accompanies perinatal white-matter damage. Trends Neurosci 2007, 30:473-478.
9. Favrais G, van de Looij Y, Fleiss B, et al. Systemic inflammation disrupts the developmental program of white matter. Ann Neurol 2011, 70:550-565.
10. Galic MA, Riazi K, Heida JG, et al. Postnatal inflammation increases seizure susceptibility in adult rats. J Neurosci 2008, 28:6904-6913.
11. Spencer SJ, Auer RN, Pittman QJ Rat neonatal immune challenge alters adult responses to cerebral ischaemia. J Cereb Blood Flow Metab 2006, 26:456-467.
12. Williamson LL, Sholar PW, Mistry RS, Smith SH, Bilbo SD Microglia and memory: modulation by early-life infection. J Neurosci 2011, 31:15511-15521.
13. Pulsinelli WA, Brierley JB, Plum F Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 1982, 11:491-498.
14. Kirino T, Tamura A, Sano K Delayed neuronal death in the rat hippocampus following transient forebrain ischemia. Acta Neuropathol (Berl) 1984, 64:139-147.
15. Pulsinelli WA, Jacewicz M, Levy DE, Petito CK, Plum F Ischemic brain injury and the therapeutic window. Ann NY Acad Sci 1997, 835:187-193.
16. Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 2005, 365:663-670.
17. Sofroniew MV Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 2009, 32:638-647.
18. Mildner A, Schlevogt B, Kierdorf K, et al. Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer's disease. J Neurosci 2011, 31:11159-11171.
19. Nagamoto-Combs K, McNeal DW, Morecraft RJ, Combs CK Prolonged microgliosis in the rhesus monkey central nervous system after traumatic brain injury. J Neurotrauma 2007, 24:1719-1742.
20. Venneti S, Lopresti BJ, Wiley CA The peripheral benzodiazepine receptor (translocator protein 18kDa) in microglia: from pathology to imaging. Prog Neurobiol 2006, 80:308-322.
21. Rupprecht R, Papadopoulos V, Rammes G, et al. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov 2010, 9:971-988.
22. Ramlackhansingh AF, Brooks DJ, Greenwood RJ, et al. Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol 2011, 70:374-383.
23. Kannan S, Saadani-Makki F, Balakrishnan B, et al. Magnitude of [(11)C]PK11195 binding is related to severity of motor deficits in a rabbit model of cerebral palsy induced by intrauterine endotoxin exposure. Dev Neurosci 2011, 33:231-240.
24. Lin CY, Chang YC, Wang ST, Lee TY, Lin CF, Huang CC Altered inflammatory responses in preterm children with cerebral palsy. Ann Neurol 2010, 68:204-212.
25. Ralay Ranaivo H, Patel F, Wainwright MS Albumin activates the canonical TGF receptor-SMAD signaling pathway but this is not required for activation of astrocytes. Exp Neurol 2010, 226:310-319.
26. Bezzi P, Domercq M, Brambilla L, et al. CXCR4-activated astrocyte glutamate release via TNF alpha: amplification by microglia triggers neurotoxicity. Nat Neurosci 2001, 4:702-710.
27. Bruhn T, Levy LM, Nielsen M, Christensen T, Johansen FF, Diemer NH Ischemia induced changes in expression of the astrocyte glutamate transporter GLT1 in hippocampus of the rat. Neurochem Int 2000, 37:277-285.
28. Hawkes CA, McLaurin J Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proc Natl Acad Sci USA 2009, 106:1261-1266.
29. Guillemin GJ, Brew BJ Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J Leukoc Biol 2004, 75:388-397.
30. Tioseco JA, Aly H, Essers J, Patel K, El-Mohandes AA Male sex and intraventricular hemorrhage. Pediatr Crit Care Med 2006, 7:40-44.
31. Donders J, Hoffman NM Gender differences in learning and memory after pediatric traumatic brain injury. Neuropsychology 2002, 16:491-499.
32. Mouton PR, Long JM, Lei DL, et al. Age and gender effects on microglia and astrocyte numbers in brains of mice. Brain Res 2002, 956:30-35.
33. Santos-Galindo M, Acaz-Fonseca E, Bellini MJ, Garcia-Segura LM Sex differences in the inflammatory response of primary astrocytes to lipopolysaccharide. Biol Sex Differ 2011, 2:7.
34. Covey MV, Loporchio D, Buono KD, Levison SW Opposite effect of inflammation on subventricular zone versus hippocampal precursors in brain injury. Ann Neurol 2011, 70:616-626.
35. Favrais G, Schwendimann L, Gressens P, Lelievre V Cyclooxygenase-2 mediates the sensitizing effects of systemic interleukin-1-beta on excitotoxic brain lesions in newborn mice. Neurobiol Dis 2007, 25:496-505.
36. Brown CM, Suzuki S, Jelks KA, Wise PM Estradiol is a potent protective, restorative, and trophic factor after brain injury. Semin Reprod Med 2009, 27:240-249.
37. Gibson CL, Gray LJ, Bath PM, Murphy SP Progesterone for the treatment of experimental brain injury: a systematic review. Brain 2008, 131:318-328.
38. Chung WS, Barres BA The role of glial cells in synapse elimination. Curr Opin Neurobiol 2011, published online Oct 27. 10.1016/j.conb.2011.10.003.
39. Sierra A, Encinas JM, Deudero JJ, et al. Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell 2010, 7:483-495.
40. Griffin R, Nally R, Nolan Y, McCartney Y, Linden J, Lynch MA The age-related attenuation in long-term potentiation is associated with microglial activation. J Neurochem 2006, 99:1263-1272.
41. Lavdas AA, Papastefanaki F, Thomaidou D, Matsas R Cell adhesion molecules in gene and cell therapy approaches for nervous system repair. Curr Gene Ther 2011, 11:90-100.
42. Maeda N, Ishii M, Nishimura K, Kamimura K Functions of chondroitin sulfate and heparan sulfate in the developing brain. Neurochem Res 2011, 36:1228-1240.
43. Jakovcevski I, Wu J, Karl N, et al. Glial scar expression of CHL1, the close homolog of the adhesion molecule L1, limits recovery after spinal cord injury. J Neurosci 2007, 27:7222-7233.
44. Tang X, Davies JE, Davies SJ Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J Neurosci Res 2003, 71:427-444.
45. Aden U, Favrais G, Plaisant F, et al. Systemic inflammation sensitizes the neonatal brain to excitotoxicity through a pro-/anti-inflammatory imbalance: key role of TNFalpha pathway and protection by etanercept. Brain Behav Immun 2010, 24:747-758.
46. Wang X, Stridh L, Li W, et al. Lipopolysaccharide sensitizes neonatal hypoxic-ischemic brain injury in a MyD88-dependent manner. J Immunol 2009, 183:7471-7477.
47. Boisse L, Mouihate A, Ellis S, Pittman QJ Long-term alterations in neuroimmune responses after neonatal exposure to lipopolysaccharide. J Neurosci 2004, 24:4928-4934.
48. Ellis S, Mouihate A, Pittman QJ Neonatal programming of the rat neuroimmune response: stimulus specific changes elicited by bacterial and viral mimetics. J Physiol 2006, 571:695-701.
49. Bilbo SD Early-life infection is a vulnerability factor for aging-related glial alterations and cognitive decline. Neurobiol Learn Mem 2010, 94:57-64.
50. Wang X, Hagberg H, Nie C, Zhu C, Ikeda T, Mallard C Dual role of intrauterine immune challenge on neonatal and adult brain vulnerability to hypoxia-ischemia. J Neuropathol Exp Neurol 2007, 66:552-561.
51. Dobrossy MD, Drapeau E, Aurousseau C, Le Moal M, Piazza PV, Abrous DN Differential effects of learning on neurogenesis: learning increases or decreases the number of newly born cells depending on their birth date. Mol Psychiatry 2003, 8:974-982.
52. Sloane JA, Batt C, Ma Y, Harris ZM, Trapp B, Vartanian T Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2. Proc Natl Acad Sci USA 2010, 107:11555-11560.
53. Segovia KN, McClure M, Moravec M, et al. Arrested oligodendrocyte lineage maturation in chronic perinatal white matter injury. Ann Neurol 2008, 63:520-530.
54. Brogdon JL, Xu Y, Szabo SJ, et al. Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function. Blood 2007, 109:1123-1130.
55. Friedman RC, Farh KK, Burge CB, Bartel DP Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009, 19:92-105.
56. Weaver IC, Champagne FA, Brown SE, et al. Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life. J Neurosci 2005, 25:11045-11054.
57. Ozanne SE, Constancia M Mechanisms of disease: the developmental origins of disease and the role of the epigenotype. Nat Clin Pract Endocrinol Metab 2007, 3:539-546.
58. Sinn DI, Kim SJ, Chu K, et al. Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation. Neurobiol Dis 2007, 26:464-472.
59. Faraco G, Pancani T, Formentini L, et al. Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain. Mol Pharmacol 2006, 70:1876-1884.
60. Madathil SK, Nelson PT, Saatman KE, Wilfred BR MicroRNAs in CNS injury: potential roles and therapeutic implications. Bioessays 2011, 33:21-26.
61. Fasanaro P, Greco S, Ivan M, Capogrossi MC, Martelli F MicroRNA: emerging therapeutic targets in acute ischemic diseases. Pharmacol Ther 2010, 125:92-104.
62. Peleg S, Sananbenesi F, Zovoilis A, et al. Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 2010, 328:753-756.
63. Shen S, Liu A, Li J, Wolubah C, Casaccia-Bonnefil P Epigenetic memory loss in aging oligodendrocytes in the corpus callosum. Neurobiol Aging 2008, 29:452-463.
64. Dash PK, Orsi SA, Moore AN Histone deactylase inhibition combined with behavioral therapy enhances learning and memory following traumatic brain injury. Neuroscience 2009, 163:1-8.
65. Perry VH Contribution of systemic inflammation to chronic neurodegeneration. Acta Neuropathol 2010, 120:277-286.
66. Vallee M, Mayo W, Dellu F, Le Moal M, Simon H, Maccari S Prenatal stress induces high anxiety and postnatal handling induces low anxiety in adult offspring: correlation with stress-induced corticosterone secretion. J Neurosci 1997, 17:2626-2636.
67. Oberlander TF, Weinberg J, Papsdorf M, Grunau R, Misri S, Devlin AM Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics 2008, 3:97-106.
68. Shi Y, Zhang X, Tang X, Wang P, Wang H, Wang Y MiR-21 is continually elevated long-term in the brain after exposure to ionizing radiation. Radiat Res 2012, 177:124-128.
69. Chahboune H, Ment LR, Stewart WB, et al. Hypoxic injury during neonatal development in murine brain: correlation between in vivo DTI findings and behavioral assessment. Cereb Cortex 2009, 19:2891-2901.
70. Dammann O, Leviton A Inflammatory brain damage in preterm newborns-dry numbers, wet lab, and causal inferences. Early Hum Dev 2004, 79:1-15.
71. Back SA, Gan X, Li Y, Rosenberg PA, Volpe JJ Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neurosci 1998, 18:6241-6253.
72. Andrews T, Zhang P, Bhat NR TNF alpha potentiates IFN gamma-induced cell death in oligodendrocyte progenitors. J Neurosci Res 1998, 54:574-583.
73. Dugas JC, Cuellar TL, Scholze A, et al. Dicer1 and miR-219 are required for normal oligodendrocyte differentiation and myelination. Neuron 2010, 65:597-611.
74. Zhao X, He X, Han X, et al. MicroRNA-mediated control of oligodendrocyte differentiation. Neuron 2010, 65:612-626.
75. Liu A, Han YR, Li J, et al. The glial or neuronal fate choice of oligodendrocyte progenitors is modulated by their ability to acquire an epigenetic memory. J Neurosci 2007, 27:7339-7343.
76. Ye F, Chen Y, Hoang T, et al. HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction. Nat Neurosci 2009, 12:829-838.
77. Johnston MV, Fatemi A, Wilson MA, Northington F Treatment advances in neonatal neuroprotection and neurointensive care. Lancet Neurol 2011, 10:372-382.
78. Thoresen M Cooling the newborn after asphyxia-physiological and experimental background and its clinical use. Semin Neonatol 2000, 5:61-73.
79. Faulkner S, Bainbridge A, Kato T, et al. Xenon augmented hypothermia reduces early lactate/N-acetylaspartate and cell death in perinatal asphyxia. Ann Neurol 2011, 70:133-150.
80. Ma D, Hossain M, Chow A, et al. Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann Neurol 2005, 58:182-193.
81. Kelen D, Robertson NJ Experimental treatments for hypoxic ischaemic encephalopathy. Early Hum Dev 2010, 86:369-377.
82. Liu Y, Barks JD, Xu G, Silverstein FS Topiramate extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in neonatal rats. Stroke 2004, 35:1460-1465.
83. Barks JD, Liu YQ, Shangguan Y, Silverstein FS Phenobarbital augments hypothermic neuroprotection. Pediatr Res 2010, 67:532-537.
84. Rogido M, Husson I, Bonnier C, et al. Fructose-1,6-biphosphate prevents excitotoxic neuronal cell death in the neonatal mouse brain. Brain Res Dev Brain Res 2003, 140:287-297.
85. Back SA, Tuohy TM, Chen H, et al. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med 2005, 11:966-972.
86. Baaten BJ, Li CR, Deiro MF, Lin MM, Linton PJ, Bradley LM CD44 regulates survival and memory development in Th1 cells. Immunity 2010, 32:104-115.
87. Klementiev B, Novikova T, Korshunova I, Berezin V, Bock E The NCAM-derived P2 peptide facilitates recovery of cognitive and motor function and ameliorates neuropathology following traumatic brain injury. Eur J Neurosci 2008, 27:2885-2896.
88. Fancy SP, Harrington EP, Yuen TJ, et al. Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nat Neurosci 2011, 14:1009-1016.
89. Buser JR, Maire J, Riddle A, et al. Arrested preoligodendrocyte maturation contributes to myelination failure in premature infants. Ann Neurol 2012, 71:93-109.
90. Monje ML, Toda H, Palmer TD Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003, 302:1760-1765.
91. Wu CW, Chen YC, Yu L, et al. Treadmill exercise counteracts the suppressive effects of peripheral lipopolysaccharide on hippocampal neurogenesis and learning and memory. J Neurochem 2007, 103:2471-2481.
92. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 2009, 29:13435-13444.
93. Thored P, Heldmann U, Gomes-Leal W, et al. Long-term accumulation of microglia with proneurogenic phenotype concomitant with persistent neurogenesis in adult subventricular zone after stroke. Glia 2009, 57:835-849.
94. Colton CA Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol 2009, 4:399-418.
95. Mikita J, Dubourdieu-Cassagno N, Deloire MS, et al. Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult Scler 2011, 17:2-15.
96. Imai F, Suzuki H, Oda J, et al. Neuroprotective effect of exogenous microglia in global brain ischemia. J Cereb Blood Flow Metab 2007, 27:488-500.
97. Vila N, Castillo J, Davalos A, Esteve A, Planas AM, Chamorro A Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. Stroke 2003, 34:671-675.
98. Yang MS, Park EJ, Sohn S, et al. Interleukin-13 and -4 induce death of activated microglia. Glia 2002, 38:273-280.
99. Madinier A, Bertrand N, Mossiat C, et al. Microglial involvement in neuroplastic changes following focal brain ischemia in rats. PloS One 2009, 4:e8101.
100. Faustino JV, Wang X, Johnson CE, et al. Microglial cells contribute to endogenous brain defenses after acute neonatal focal stroke. J Neurosci 2011, 31:12992-13001.
101. Lalancette-Hebert M, Gowing G, Simard A, Weng YC, Kriz J Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci 2007, 27:2596-2605.
102. Meyer U, Feldon J, Dammann O Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?. Pediatr Res 2011, 69:26R-33R.
103. Reynolds AD, Banerjee R, Liu J, Gendelman HE, Mosley RL Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease. J Leukoc Biol 2007, 82:1083-1094.
104. Polfliet MM, Zwijnenburg PJ, van Furth AM, et al. Meningeal and perivascular macrophages of the central nervous system play a protective role during bacterial meningitis. J Immunol 2001, 167:4644-4650.
105. Wilson EH, Weninger W, Hunter CA Trafficking of immune cells in the central nervous system. J Clin Invest 2010, 120:1368-1379.
106. Ren M, Leng Y, Jeong M, Leeds PR, Chuang DM Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. J Neurochem 2004, 89:1358-1367.
107. Suh HS, Choi S, Khattar P, Choi N, Lee SC Histone deacetylase inhibitors suppress the expression of inflammatory and innate immune response genes in human microglia and astrocytes. J Neuroimmune Pharmacol 2010, 5:521-532.
108. McCarthy MM, Auger AP, Bale TL, et al. The epigenetics of sex differences in the brain. J Neurosci 2009, 29:12815-12823.
109. Fleiss B, Nilsson M, Blomgren K, Mallard C. Neuroprotection by the histone deacetylase inhibitor trichostatin A in a model of lipopolysaccharide sensitized neonatal hypoxic-ischemic brain injury. J Neuroinflamm (in press).
110. Dharap A, Bowen K, Place R, Li LC, Vemuganti R Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. J Cereb Blood Flow Metab 2009, 29:675-687.
111. Ponomarev ED, Veremeyko T, Barteneva N, Krichevsky AM, Weiner HL MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-alpha-PU.1 pathway. Nat Med 2011, 17:64-70.
112. Ferrarello F, Baccini M, Rinaldi LA, et al. Efficacy of physiotherapy interventions late after stroke: a meta-analysis. J Neurol Neurosurg Psychiatry 2011, 82:136-143.
113. van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor function. J Neurosci 2010, 30:9603-9611.
114. Titomanlio L, Bouslama M, Le Verche V, et al. Implanted neurosphere-derived precursors promote recovery after neonatal excitotoxic brain injury. Stem Cells Dev 2011, 20:865-879.
115. Daadi MM, Davis AS, Arac A, et al. Human neural stem cell grafts modify microglial response and enhance axonal sprouting in neonatal hypoxic-ischemic brain injury. Stroke 2010, 41:516-523.
116. Zhang L, Li Y, Zhang C, Chopp M, Gosiewska A, Hong K Delayed administration of human umbilical tissue-derived cells improved neurological functional recovery in a rodent model of focal ischemia. Stroke 2011, 42:1437-1444.
117. Covey MV, Jiang Y, Alli VV, Yang Z, Levison SW Defining the critical period for neocortical neurogenesis after pediatric brain injury. Dev Neurosci 2010, 32:488-498.
118. Osredkar D, Sall JW, Bickler PE, Ferriero DM Erythropoietin promotes hippocampal neurogenesis in in vitro models of neonatal stroke. Neurobiol Dis 2010, 38:259-265.
119. Gressens P, Marret S, Hill JM, et al. Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain. J Clin Invest 1997, 100:390-397.
120. Johnston BM, Mallard EC, Williams CE, Gluckman PD Insulin-like growth factor-1 is a potent neuronal rescue agent after hypoxic-ischemic injury in fetal lambs. J Clin Invest 1996, 97:300-308.
121. Destot-Wong KD, Liang K, Gupta SK, et al. The AMPA receptor positive allosteric modulator, S18986, is neuroprotective against neonatal excitotoxic and inflammatory brain damage through BDNF synthesis. Neuropharmacology 2009, 57:277-286.
122. Cotman CW, Berchtold NC, Christie LA Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci 2007, 30:464-472.
123. Seymour AB, Andrews EM, Tsai SY, et al. Delayed treatment with monoclonal antibody IN-1 1 week after stroke results in recovery of function and corticorubral plasticity in adult rats. J Cereb Blood Flow Metab 2005, 25:1366-1375.
124. Johansson BB Functional outcome in rats transferred to an enriched environment 15 days after focal brain ischemia. Stroke 1996, 27:324-326.
125. Sun Y, Jin K, Xie L, et al. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 2003, 111:1843-1851.
126. Husson I, Mesples B, Bac P, Vamecq J, Evrard P, Gressens P Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. Ann Neurol 2002, 51:82-92.
127. Welin AK, Svedin P, Lapatto R, et al. Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion. Pediatr Res 2007, 61:153-158.
128. Gitto E, Reiter RJ, Amodio A, et al. Early indicators of chronic lung disease in preterm infants with respiratory distress syndrome and their inhibition by melatonin. J Pineal Res 2004, 36:250-255.
129. Zhu C, Kang W, Xu F, et al. Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics 2009, 124:e218-e226.